Loss of functional kidney tissue after nephrectomy for kidney cancer contributes to the onset of chronic kidney disease (CKD).

Feb. 19, 2004 — Adjuvant treatment with autologous renal tumor cell vaccine seems to be beneficial in patients with organ-confined renal cell carcinoma, according to the results of a phase III, ...

The presence and number of kidney cysts, particularly in the medulla, may be an additional imaging-based biomarker for progressive CKD after radical nephrectomy for kidney cancer. Among patients who ...

Kidney removal, medically known as a nephrectomy, is a major surgical procedure performed to treat kidney disease, cancer, or to enable a healthy individual to donate a kidney. While the operation can ...

There are multiple potential applications for circulating tumor (ct)DNA in kidney cancer. The post-nephrectomy remission, adjuvant therapy decision, and monitoring for response or progression on ...

Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...

Part B of the Checkmate 914 trial showed no disease-free survival (DFS) benefit with adjuvant nivolumab monotherapy in patients with localized renal cell carcinoma (RCC) at high risk of recurrence ...

Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone of treatment, with excellent outcomes in many cases. Patients are ...

Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic kidney disease (ADPKD), according to a study published online Dec. 17 in Urology ...